<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80523">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01796847</url>
  </required_header>
  <id_info>
    <org_study_id>LAVPTEN</org_study_id>
    <nct_id>NCT01796847</nct_id>
  </id_info>
  <brief_title>Relationship Between PTEN and Glycemic Variability and Outcome in Critically Ill Patients</brief_title>
  <acronym>GLUPTEN</acronym>
  <official_title>Influence of PTEN on Glycemic Variability and Clinical Outcome in the Critically Ill Patient.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glycemic variability in critically ill patients is a recognized negative prognostic factor.
      The molecular mechanisms determining inter-patients variability in glucose metabolism during
      stress are not fully understood. The Phosphatase and Tensin homolog (PTEN) is known to
      influence glucose homeostasis by interfering in intracellular insulin signaling.

      Aim of this study is to ascertain whether differential expression of PTEN in critically ill
      patients correlates with glycemic variability and clinical outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Day 1 up to day 28</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycemic variability as expressed by standard deviation of the glycemia measurements</measure>
    <time_frame>Day 1 up to day 28</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Critical Illness</condition>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>PTEN, hyperglycemia</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Truma patients admitted to general ICU
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  trauma

          -  provision informed consent

        Exclusion Criteria:

          -  diabetes

          -  impaired fasting glucose levels
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandro Laviano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapienza University of Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Laviano, MD</last_name>
    <phone>+39-0649973902</phone>
    <email>alessandro.laviano@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Rome La Sapienza, University Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donatella Dell'Utri, MD</last_name>
      <email>donatella.dellutri@uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Laviano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 21, 2013</lastchanged_date>
  <firstreceived_date>February 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Alessandro Laviano</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>ICU</keyword>
  <keyword>Hyperglycemia</keyword>
  <keyword>Length of stay</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
